Published in Hematology Week, May 21st, 2007
"Typically, no single treatment is feasible. So far, numerous substances have been used as treatments and the majority of these are antioxidants," wrote O. Kayiran and colleagues, Ankara Numune Education and Research Hospital.
The researchers concluded: "In this article, a combined therapy is implemented for a patient suffering...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.